Not sure why either. It is probably good practice to market it as 'price sensitive' and they may look to do it to all contract win announcements moving forward.
Sale to AMP is a positive - great to see a big insurance firms on board. OCLs investment in this area will hopefully continue to pay off.
A very well managed business.
- Forums
- ASX - By Stock
- Ann: DECD SA selects Objective
Not sure why either. It is probably good practice to market it...
Featured News
Add OCL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.52 |
Change
0.200(1.15%) |
Mkt cap ! $1.408B |
Open | High | Low | Value | Volume |
$17.38 | $17.70 | $17.38 | $1.311M | 74.89K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 124 | $17.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.66 | 737 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7125 | 2.750 |
2 | 1356 | 2.710 |
2 | 1194 | 2.600 |
1 | 2997 | 2.510 |
2 | 44658 | 2.500 |
Price($) | Vol. | No. |
---|---|---|
2.780 | 3 | 1 |
2.790 | 3 | 1 |
2.800 | 5003 | 2 |
2.850 | 2206 | 1 |
2.950 | 354 | 1 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
OCL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online